Your browser doesn't support javascript.
loading
Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.
Poovassery, Jayakumar S; Kang, Jeffrey C; Kim, Dongyoung; Ober, Raimund J; Ward, E Sally.
Afiliação
  • Poovassery JS; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Kang JC; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center, College of Medicine, College Station, TX.
  • Kim D; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center, College of Medicine, College Station, TX.
  • Ober RJ; Department of Biomedical Engineering, Texas A&M University, College Station, TX.
  • Ward ES; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center, College of Medicine, College Station, TX.
Int J Cancer ; 137(2): 267-77, 2015 Jul 15.
Article em En | MEDLINE | ID: mdl-25471734
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Receptor ErbB-2 / Receptor ErbB-3 / Neuregulina-1 / Inibidores de Fosfoinositídeo-3 Quinase / Anticorpos Limite: Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Receptor ErbB-2 / Receptor ErbB-3 / Neuregulina-1 / Inibidores de Fosfoinositídeo-3 Quinase / Anticorpos Limite: Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article